Precision Biosciences (DTIL) EPS (Basic) Growth (1y) (2019 - 2026)
Precision Biosciences (DTIL) EPS (Basic) Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 7.74% |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.70 Bn | 3.93 Bn | -4.72% |
| 3 | Argenx Se | 65.23 Bn | 60.05 Bn | 1.37 Bn | 88.81% |
| 4 | Moderna | 60.16 Bn | 55.02 Bn | 52.00 Mn | 7.59% |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 143.95% |
| 6 | Alnylam Pharmaceuticals | 31.86 Bn | 28.55 Bn | 992.69 Mn | 322.67% |
| 7 | BioNTech SE | 28.24 Bn | 9.85 Bn | 668.28 Mn | -147.33% |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 96.41% |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | -16.29% |
| 10 | Precision Biosciences | 225.73 Mn | 138.18 Mn | - | 62.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 63.90% |
| Mar 31, 2026 | 84.80% |
| Dec 31, 2025 | 129.01% |
| Sep 30, 2025 | 42.15% |
| Jun 30, 2025 | -189.82% |
| Mar 31, 2025 | -274.00% |
| Dec 31, 2024 | -370.11% |
| Sep 30, 2024 | -485.05% |
| Jun 30, 2024 | 195.93% |
| Mar 31, 2024 | 79.56% |
| Dec 31, 2023 | 75.97% |
| Sep 30, 2023 | 147.00% |
| Jun 30, 2023 | 85.29% |
| Mar 31, 2023 | 82.20% |
| Dec 31, 2022 | 80.30% |
| Sep 30, 2022 | 79.92% |
| Jun 30, 2022 | -255.91% |
| Mar 31, 2022 | -64.09% |
| Dec 31, 2021 | -12.10% |
| Sep 30, 2021 | 32.75% |